Direct emissions
750,616
tCO2e
Back to search resultsEmissions
Sustainability
Scope
REPORTED REPORTED REPORTED REPORTED REPORTED ESTIMATED REPORTED REPORTED REPORTED REPORTED REPORTED ESTIMATED ESTIMATED ESTIMATED ESTIMATED ESTIMATED ESTIMATED 
Read the full scoring methodologyOur white paper covers exactly how the Mycelium Score and Transparency Score are calculated, including the normalisation process and what earns a 10/10.Download the white paper (PDF)
Mycelium Score4.4 / 10A mid-pack scoreATransparencyVery HighExtensive disclosure across almost all key areas
Explore carbon emissions data for Aurobindo Pharma Limited. Mycelium helps you review reported emissions, disclosure status, Scope 1, Scope 2 and Scope 3 data, climate targets and sustainability information in one company profile.
This profile brings together available carbon emissions data for Aurobindo Pharma Limited, including reported figures, modelled estimates, disclosure documents and sustainability indicators, so you can review its emissions and compare its performance against similar companies. It is one entry in the Mycelium emissions database. Read how we source and check this data.
Emissions
Carbon emissions
Total yearly emissions across all scopes
1,839,526tCO2e(Location Based)(Mycelium adjusted)
- Reported by Aurobindo Pharma Limited
- 1,585,609 tCO₂e
- Estimated by Mycelium
- 253,917 tCO₂e
Aurobindo Pharma Limited reported 86% of the adjusted total. Mycelium estimated the remaining 14% for the categories it did not disclose.
Scope 1
tCO2e
750,616
Scope 2 (Location Based)
tCO2e
474,772
Scope 3 total
tCO2e
614,138
Figures from pages 28 and 31 of the source report
Scope 3 reported
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
Something wrong? Contribute to this dataset
See the scope breakdownProvenance
Emissions
Factors
0.417kgCO2e / $
Supplier specific emission factors (kgCO2e / $)
Modelled
Reported
UpstreamScope 1, 2 + upstream Scope 3
0.417
0.400
Total+ all Scope 3
–
0.419
Per US dollar of revenue. Mycelium models the upstream factor only.
Which figure should I use?
Estimating your own supply-chain emissions from spend with this company? Use Upstream Modelled. The GHG Protocol defines purchased-goods emissions as cradle-to-gate, which means this company's own operations plus its upstream supply chain. Any of those emissions the company has not disclosed are filled with modelled estimates, so a transparent company is not unfairly penalised against one that simply has not reported.
Looking at what the company filed itself? Use the Reported column. Total Reported also includes downstream emissions, such as the lifetime use of the products this company sells, which the GHG Protocol attributes to the users of those products rather than to customers buying goods and services.
Reported counts only emissions the company has filed itself. A blank or low Reported cell does not mean those emissions do not exist, just that the company has not disclosed them. When Upstream Reported sits close to Upstream Modelled, that is a positive signal: the company has disclosed most of its upstream emissions.
Sustainability
Snapshot
Based on reported data, retrieved with AI
- Aurobindo Pharma Limited reported 1,585,609 tCO₂e in 2025.
- Scope 3 accounted for 23% of reported emissions.
- Reported across 8 of 15 GHG Protocol Scope 3 categories.
- Scope 2 reported under the location based methodology.
According to available emissions disclosures, Aurobindo Pharma Limited reported total yearly emissions of 1,585,609 tCO₂e in 2025. Scope 1 emissions accounted for 47% of the reported footprint, indicating the company's own operations, such as fuel use, facilities and vehicles, were the most significant contributors to its carbon footprint.
The company achieved a Mycelium Score of 4.4, placing it mid-pack within its sector for sustainability performance, and received a transparency score of 93.3, an exceptional result, reflecting open disclosure across nearly every key emissions metric.
Scope
breakdown
Scope 1 emissions
Direct emissions from sources the company owns or controls, such as fuel use, facilities and vehicles.
Scope 2 emissions
Indirect emissions from purchased energy, including electricity, heating and cooling.
Location based
474,772
tCO2eMarket based
–
tCO2eScope 3 emissions
Wider value chain emissions across the 15 GHG Protocol categories, from purchased goods and business travel to investments, where reported.
Cat 1
Purchased goods & services
5,713
tCO2eCat 2
Capital goods
11,031
tCO2eCat 3
Fuel & energy related activities
246,964
tCO2eCat 4
Upstream transportation & distribution
66,468
tCO2eCat 5
Waste generated in operations
11,348
tCO2eCat 6
Business travel
1,447
tCO2eCat 7
Employee commuting
11,141
tCO2eCat 8
Upstream leased assets
1,879
tCO2eCat 9
Downstream transportation & distribution
70,698
tCO2eCat 10
Processing of sold products
10,040
tCO2eCat 11
Use of sold products
134,270
tCO2eCat 12
End-of-life treatment of sold products
4,695
tCO2eCat 13
Downstream leased assets
3,005
tCO2eCat 14
Franchises
12,820
tCO2eCat 15
Investments
22,617
tCO2e7 values were derived via Mycelium's normalisation process rather than reported by the company. A cell marked “ESTIMATED” is a figure the company did not disclose, modelled by Mycelium.
Verification
Independent third parties involved in checking or preparing Aurobindo Pharma Limited's emissions data.
Independent assurance
Independently assured(reasonable assurance)by M/s Sharp & Tannan Associatesfor 2025
Contact Info
Website
www.aurobindo.comCountry
India
Browse carbon emissions data by industry
Jump straight into the sectors users explore most, or view all industries.
How scoring works
How the Mycelium Score is calculated
The Mycelium Score is out of 10. Up to 6.5 points reflect carbon intensity vs peers in the same NACE section (emissions normalised against revenue, log-scaled between the 5th and 95th percentile of each company's latest reporting year in that section; a section needs at least 5 companies to be benchmarked). The band above 6.5 is earned through verified data quality on a claimed profile: declaring every reporting category yourself (up to 2.0), preparation by a carbon accountant (2.0) and independently audited figures (2.0). The total is multiplied by the transparency score and capped at 10. A disclosure with an implausibly large figure (Scope 1 or 2 over 300 million tonnes, a Scope 3 figure over 2 billion tonnes or a total over 2.5 billion tonnes) is not scored until it has been checked.
A higher score means lower carbon intensity than sector peers, backed by data that's third-party verified, claimed by the company, and fully disclosed. Aurobindo Pharma Limited's score sits at the top of this page and in the score panel. Without a revenue figure to measure carbon intensity, or an industry classification to compare it within, a company has no score.
How the Transparency Score is calculated
The Transparency Score is the share of a company's estimated footprint that it reported itself, graded from A (very high) down to F (very low). Where a category is missing, Mycelium models what it would hold for a company of that size and industry and counts it as undisclosed, so an unreported category where the bulk of emissions sit hurts far more than a minor one. Unreported downstream categories (9 to 15) count at a quarter of their modelled size in this share; the carbon intensity behind the score still counts them in full. A Scope 3 total filed without a category breakdown earns very little credit for the part left unattributed, because it does not show which categories are inside it: a company can count business travel, leave purchased goods out entirely, and the total looks the same. Without a revenue figure the footprint cannot be modelled, so the company has no Transparency Score.
For Aurobindo Pharma Limited, the single biggest gap is Use of sold products (Scope 3 Category 11). Mycelium estimates it accounts for around 7% of the company's estimated footprint, yet it hasn't been disclosed. Leaving a bucket this large unreported is what's holding the transparency score down.
Other material categories Aurobindo Pharma Limited hasn't disclosed:
- Upstream transportation & distribution (Scope 3 Category 4), around 4% of the estimated footprint
In total, roughly 14% of Aurobindo Pharma Limited's estimated emissions sit in categories it hasn't reported. Disclosing these would be the fastest way to raise the transparency score.
Read the full scoring methodologyOur white paper covers exactly how the Mycelium Score and Transparency Score are calculated, including the normalisation process and what earns a 10/10.Download the white paper (PDF)Compare Aurobindo Pharma Limited with similar companies
Aurobindo Pharma Limited carbon emissions FAQs
What are Aurobindo Pharma Limited's carbon emissions?
In its 2025 reporting year, Aurobindo Pharma Limited disclosed total emissions of 1,585,609 tCO2e across all scopes. Including Mycelium estimates for undisclosed categories, the adjusted total is 1,839,526 tCO2e. Scope 1 accounted for the largest share of the reported total, around 47%.
Does Aurobindo Pharma Limited report Scope 1, Scope 2 and Scope 3 emissions?
For 2025, Aurobindo Pharma Limited's available disclosure covers Scope 1 (750,616 tCO2e), Scope 2 (474,772 tCO2e) and Scope 3 across 8 of the 15 GHG Protocol categories. Figures not reported by the company are shown as modelled estimates and labelled as such.
How transparent is Aurobindo Pharma Limited's emissions reporting?
Aurobindo Pharma Limited has a Mycelium transparency score of 93.3 out of 100. The score is the share of the company's estimated footprint that it reported itself, so an undisclosed category where most of its emissions sit weighs far more than a minor one.
Is Aurobindo Pharma Limited sustainable?
Mycelium measures sustainability through carbon emissions data rather than giving a yes or no verdict. Aurobindo Pharma Limited has a Mycelium Score of 4.4 out of 10, which reflects its emissions intensity against sector peers together with how transparent and well-verified its reporting is. The emissions figures and disclosure documents on this page give the fuller picture.
Is Aurobindo Pharma Limited environmentally friendly?
Carbon emissions are one measurable part of environmental impact, and the part Mycelium tracks. Aurobindo Pharma Limited disclosed 1,585,609 tCO2e for 2025, and its Mycelium Score of 4.4 out of 10 shows how that performance compares with similar companies in its sector.
Learn more about our methodology and where this data comes from.